ARTICLE | Clinical News
Bordetella pertussin and parapertussin molecular test regulatory update
September 29, 2008 7:00 AM UTC
Health Canada granted marketing approval for EraGen's in vitro molecular diagnostic test for Bordetella pertussis and parapertussis. The test is to be performed on the company's MultiCode-RTx real-tim...